59
DIAGNOSIS & TREATMENT OF PARKINSON’S DISEASE May 7, 2008 Sadhana Prasad Symposium on Changes and Challenges in Geriatric Care Brought to you by

Treatment of parkinson’s disease

Embed Size (px)

DESCRIPTION

Treatment of parkinson’s disease

Citation preview

Page 1: Treatment of  parkinson’s disease

DIAGNOSIS & TREATMENT OF PARKINSON’S DISEASE

May 7, 2008Sadhana Prasad

Symposium on Changes and Challenges in Geriatric Care Brought to you by

Page 2: Treatment of  parkinson’s disease

Disclosures

• Work with various pharmaceutical companies intermittently

• Honorarium will be donated

Brought to you by

Page 3: Treatment of  parkinson’s disease

Brought to you by

Page 4: Treatment of  parkinson’s disease

Brought to you by

Page 5: Treatment of  parkinson’s disease

OBJECTIVES

1. Illustrate medications and conditions that may mimic PD

2. Describe the early symptoms of Parkinson’s Disease (PD)

3. Discuss initiating and stopping medications

Brought to you by

Page 6: Treatment of  parkinson’s disease

Parkinson’s Disease

Characterized by: (Slow,Stiff,Shaky)

• Bradykinesia *

• Rigidity *

• Rest tremor--3-6Hz pill-rolling (absent 1/3)

• Postural instability

Brought to you by

Page 7: Treatment of  parkinson’s disease

Parkinson’s Disease (PD)

• First description 1817 Parkinson, James An Essay on the Shaking Palsy, Sherwood, Neely, and Jones,

London

• Progressive neurodegenerative disease

• Affects ages 40 onwards, mean age at diagnosis 70.5

• Complex disorder with motor, non-motor, neuropsychiatric features

Brought to you by

Page 8: Treatment of  parkinson’s disease

Disease vs Syndrome

• Disease = a morbid process having characteristic symptoms; pathology, etiology, and prognosis may be known

• Syndrome = a set of symptoms occurring together; different etiologies but similar presentation

Brought to you by

Page 9: Treatment of  parkinson’s disease

Parkinson’s Syndromes

Metabolic causes--

• Hypothyroidism

• Hypoparathyroidism

• Alcohol withdrawl (pseudoparkinsonism)

• Chronic liver failure

• Wilson’s disease

Brought to you by

Page 10: Treatment of  parkinson’s disease

P. Syndromes

Medications**/chemicals—• neuroleptics (typicals more than the atypicals),• SSRI (selective serotonin reuptake inhibitors), • metoclopromide/maxeran, • Reserpine, • MPTP, • in Methcathinone (ephedrone) users – high

plasma Manganese levels (NEJM Mar 6, 2008)• CO, cyanide, organic solvents, carbon disulfide

Brought to you by

Page 11: Treatment of  parkinson’s disease

P. Syndromes

Structural Causes—

• Strokes

• Tumors

• Chronic subdurals

• NPH (Normal Pressure Hydrocephalus)

Brought to you by

Page 12: Treatment of  parkinson’s disease

P.Syndromes

Lewy Body spectrum of Diseases (DLB=Dementia with LB)---

---early onset visual (or other) hallucinations

---fluctuating cognitive abilities

---sleep disorders

---neuroleptic sensitivity, even to atypicals

Brought to you by

Page 13: Treatment of  parkinson’s disease

P. Syndromes

PSP (progressive supranuclear palsy)—or Steeles Richardson Olszewski Syndrome

---gaze abnormalities

---postural instability, early unexplained falls

---bulbar features—dysphonia, dysarthria, dysphagia

---rapidly progressive---median 6 yrs.

Brought to you by

Page 14: Treatment of  parkinson’s disease

P. Syndromes

CBD (cortico basal degeneration)---

---Asymmetric parkinsonism

---postural instability

---ideomotor apraxia

---aphasia

---alien limb phenomenon

---impaired cortical sensationsBrought to you by

Page 15: Treatment of  parkinson’s disease

P. Syndromes

Multi System Atrophy-- (alpha-synuclein + glial cytoplasmic inclusions, autonomic dysfunction, pyramidal signs)

• Shy Drager Syndrome,

• Olivopontocerebellar atrophy,

• Striatonigral degeneration

Brought to you by

Page 16: Treatment of  parkinson’s disease

P. Syndromes

Other Neurodegenerative Disorders—

• Alzheimer’s Disease, later stages**

• Huntington’s Disease (rigid form)

• Frontotemporal Dementia with Parkinsonism, Chromosome-17 linked (FTDP-17)

• Spinocerebellar ataxias

Brought to you by

Page 17: Treatment of  parkinson’s disease

P. Syndromes

Infections---• encephalitis• HIV/AIDS• Neurosyphilis• Toxoplasmosis• CJD (Creuzfeld Jakob)--prion disease• Progressive multifocal

leukoencephalopathyBrought to you by

Page 18: Treatment of  parkinson’s disease

P. Syndrome

Essential Tremor---

---action tremor (not rest tremor)

---more rapid (greater than 3-6 Hz)

---usually hands, but can also affect legs, head/chin, voice, trunk

---can present with falls if legs and trunk involved

Brought to you by

Page 19: Treatment of  parkinson’s disease

P. Disease

??DIAGNOSIS??

Brought to you by

Page 20: Treatment of  parkinson’s disease

P. Dis -- Diagnosis

• A clinical diagnosis

• Cardinal features: Bradykinesia, rigidity

• Trial of sinemet (Levodopa/carbidopa)

• Confirmatory test: neuropathologic (autopsy)

Brought to you by

Page 21: Treatment of  parkinson’s disease

P. Disease-Diagnosis

• 1/3 will not respond to levodopa therapy

• 1/5 with P. Syndrome will respond to levodopa

---Follow- up with time needed to clarify diagnosis

Brought to you by

Page 22: Treatment of  parkinson’s disease

P. Disease---Diagnosis

Minimum therapeutic dose:

---300mg levodopa per day in divided doses

---can be lower in biologically old old

---vast majority will need 400-600mg levodopa daily to achieve significant benefit

Brought to you by

Page 23: Treatment of  parkinson’s disease

P. Disease- Diagnosis

Consider alternative diagnosis if:

• Early falls (postural instability)

• Poor response to levodopa

• Dysautonomia (urinary retention/atonic bladder, incontinence, orthostatic hypotension, impotence)

• No rest tremor (in 1/3)

Brought to you by

Page 24: Treatment of  parkinson’s disease

P. Disease-Diagnosis

Alternative Diagnosis cont’d…

• Cerebellar signs

• Positive Babinski

• Apraxia

• Gaze abnormailities

• Dementia concurrently with Parkinsonism

• StrokesBrought to you by

Page 25: Treatment of  parkinson’s disease

P. Disease

INVESTIGATIONS:

• TSH

• Calcium, albumin

• CT head

Brought to you by

Page 26: Treatment of  parkinson’s disease

OBJECTIVES

1. Illustrate medications and conditions that may mimic PD

2. Describe the early symptoms of Parkinson’s Disease (PD)

3. Discuss initiating and stopping medications

Brought to you by

Page 27: Treatment of  parkinson’s disease

PD- CASE

• Mr AB, married, active farmer, stressed care-giver

• Drove his wife to the clinic, wife to see me re agitated dementia

• One son also attended

• Mr AB –stressed care-giver, on paxil (SSRI)

Brought to you by

Page 28: Treatment of  parkinson’s disease

PD- case

Mr. AB--- stressed caregiver

• Slightly flexed posture

• Slightly bradykinetic

• Slightly diminished facial expression

• No difficulty turning, getting in/out of armless chair

Brought to you by

Page 29: Treatment of  parkinson’s disease

PD-case

“I don’t have Parkinson’s Disease!!”

Brought to you by

Page 30: Treatment of  parkinson’s disease

PD- case

Mr. AB---• 1 month later, referred re ? PD??• CT head, TSH, Ca normal• Slowing down x 1 yr, hypophonia, denied

trouble turning in bed but took 5 tries in clinic, trouble getting out of soft chair, stopped taking baths x 3 years, mild rest tremor R hand, trouble doing up buttons and laces

Brought to you by

Page 31: Treatment of  parkinson’s disease

IADLInstrumental Activities of Daily Living

• S shopping

• H housework

• A accounting

• F food preparation

• T transportation

Brought to you by

Page 32: Treatment of  parkinson’s disease

ADLActivities of Daily Living

• D dressing

• E eating

• A ambulation

• T toiletting

• H hygiene

Brought to you by

Page 33: Treatment of  parkinson’s disease

PD- case 1

Brought to you by

Page 34: Treatment of  parkinson’s disease

PD-case 1

clock

Brought to you by

Page 35: Treatment of  parkinson’s disease

PD –Case 1

Diagnosis:

Parkinson’s disease ---Hoehn & Yahr’s** stage 2

Brought to you by

Page 36: Treatment of  parkinson’s disease

Hoehn and Yahr scale

• 1. Unilateral involvement only, usually with minimal or no functional disability

• 2. Bilateral or midline involvement without impairment of balance

• 3. Bilateral disease; mild to moderate disability with impaired postural reflexes; physically independent

• 4. Severely disabling disease; still able to walk or stand unassisted

• 5. Confinement to bed or wheelchair unless aidedHoehn, MM, Yahr, MD. Parkinsonism: onset, progression and mortality. Neurology 1967;

17:427. Brought to you by

Page 37: Treatment of  parkinson’s disease

PD- case 1

• MTO notified, “not to cancel license”

• Paxil *

• Sinemet regular 100/25 mg ½ tid, increase by ½ weekly till 1 tid

• Calcium and vitamin D3

• 2 months later, smiling, clock better, moving better, still flexed, no fallsBrought to you by

Page 38: Treatment of  parkinson’s disease

PD-case 1

clock

Brought to you by

Page 39: Treatment of  parkinson’s disease

PD—other issues

• Depression• Dementia• Driving• Falls• Neuropsychiatric features• “slowing down of thought processes” (the

clock in Mr AB)• Constipation

Brought to you by

Page 40: Treatment of  parkinson’s disease

PD-Treatment

????

Brought to you by

Page 41: Treatment of  parkinson’s disease

OBJECTIVES

1. Illustrate medications and conditions that may mimic PD

2. Describe the early symptoms of Parkinson’s Disease (PD)

3. Discuss initiating and stopping medications

Brought to you by

Page 42: Treatment of  parkinson’s disease

PD--Treatment

• Geared towards mobility—levodopa, dopamine agonists, MAO B inhibitors

• Rest tremor, cosmetic—anticholinergics (may worsen cognition)

• Postural imbalance—no pharmacological treatment; exercise, gait aids, prevent fractures (Ca, Vit D3, +/- bisphosphonates)

• Dyskinesias-- ?amantadine (no clear evidence) Almeida,QJ, Recent Patents on CNS Drug Discovery, 2008:3, 5--54

Brought to you by

Page 43: Treatment of  parkinson’s disease

PD--Which pharmaceutical?

In Elderly--

• Levodopa/ carbidopa (sinemet) – regular vs CR (controlled release)

or

Levodopa/ benserazide (prolopa) – regular vs HBS

• COMT- inhibitor– entacapone (comtan)Brought to you by

Page 44: Treatment of  parkinson’s disease

PD- medications

LevodopaLevodopa• Well-established, for bradykinesia and

rigidity• SE: nausea, orthostatic hypotension• Combined with peripheral decarboxylase

inhibitor (carbidopa, benserazide) to prevent conversion to dopamine in the periphery before it crosses blood brain barrier

Brought to you by

Page 45: Treatment of  parkinson’s disease

PD- medications

Levodopa (l-dopa) -- l-dopa / carbidopa = sinemet reg. or CR-- l-dopa / benserazide = prolopa, medopar or

medopar HBS• Competes with amino acids from protein for GI

absorption• Regular-- before meals, quick in quick out, T1/2

= 90 min• CR--- With meals,Controlled Release, slow in

slow out, need 30% more to achieve same effect as reg. dose, erratic absorption in elderly

Brought to you by

Page 46: Treatment of  parkinson’s disease

PD-medications

L-dopa cont’d

• SE- Nausea (Rx Domperidone)

-Hallucinations (Rx lower dose, atypical n neuroleptics)

-somnolence, confusion, agitation

-motor fluctuations- after sev yrs of Rx

Brought to you by

Page 47: Treatment of  parkinson’s disease

PD- medications

L-dopa cont’d

• Motor fluctuations (in 50%, after 5-10yrs)-wearing-off– Rx COMT – inhibitor*, ?CR -dyskinesias –(??Rx amantadine??)-dystonias -variety of complex fluctuations in motor

functionBrought to you by

Page 48: Treatment of  parkinson’s disease

PD- medications

L-dopa cont’d

• Discontinuation—

- gradually –over weeks,

- to prevent malignant neuroleptic like syndrome or akinetic crisis

Brought to you by

Page 49: Treatment of  parkinson’s disease

PD-medications

L-dopa cont’d• Dopaminergic dysregulation syndrome (DDS)—

tolerance to mood elevating effects- Compulsive use of dopaminergic drugs- Early onset males- Cyclical mood disorder - Impulse control disorder (hypersexuality,

pathologic gambling)Giovannoni, G, Hedonistic homeostatic dysregulation…J. Neurol Neurosurg Psychiatry

2000; 68:243 Brought to you by

Page 50: Treatment of  parkinson’s disease

PD- medications

COMT – inhibitorCOMT – inhibitor-Catechol-O-Methyl Transferase Inhibitor-((eg Tolcapone (Tasmar)---off market due to

fulminant hepatitis causing 3 deaths))-eg Entacapone (Comtan)-for wearing-off at end-of-dose of L-dopa-dose 200mg-1600mg, divided, daily, with L-dopa-SE-diarrhea in 5%, due to increased

dopaminergic stimulation from L-dopa availability

Brought to you by

Page 51: Treatment of  parkinson’s disease

PD-medications

Dopamine Agonists: adjunct Rx to L-dopa.-Ergotamines—bromocriptine, ((pergolide)),

((cabergoline)) SE-same as L-dopa, uncommon Raynaud’s,

erythromelalgia, retroperitoneal/pulmonary fibrosis

-Non-Ergot—pramipexole, ropinirole, ((transdermal rotigotine))

SE—same as L-dopa, Sudden somnolence –caution with driving

Brought to you by

Page 52: Treatment of  parkinson’s disease

PD-medications

MAO-B inhibitors-MAO-B inhibitors--adjunct Rx to L-dopa

-eg selegiline (eldepryl), rasagiline

-somewhat helpful in young, early in disease

-neuroprotective properties in animal models only

Arch Neurology. 2002; 59:1937

Brought to you by

Page 53: Treatment of  parkinson’s disease

PD-medications

AnticholinergicsAnticholinergics—adjunct Rx to L-dopa, best avoided in elderly

-acetylcholine (ACh) and dopamine in balance in basal ganglia

-decrease Ach to balance decrease in L-dopa-eg trihexyphenidyl (artane), benztropine

(cogentin), orphenadrine, procyclidine (kemadrin)

-SE-confusion, hallucinations, dry mouth, blurred vision, constipation, nausea, u. retention, glaucoma

Brought to you by

Page 54: Treatment of  parkinson’s disease

PD-medications

Amantadine-adjunct to L-dopa, best avoided in elderly

-for dyskinesias

-Antiviral agent—mechanism unknown

-NMDA-receptor antagonist properties-interferes with excessive glutamate

-SE-livedo reticularis, ankle edema, hallucinations

Brought to you by

Page 55: Treatment of  parkinson’s disease

PD- Medications

When do you stop the medications?

--ALWAYS taper gradually over days to weeks to avoid NM-like syndrome

--unable to take meds (dysphagia)

--significant, intolerable SE impairing QOL

--end-stage--- “infection comes as a friend”

Brought to you by

Page 56: Treatment of  parkinson’s disease

OBJECTIVES

1. Illustrate medications and conditions that may mimic PD

2. Describe the early symptoms of Parkinson’s Disease (PD)

3. Discuss initiating and stopping medications

Brought to you by

Page 57: Treatment of  parkinson’s disease

This platform has been started by Parveen Kumar Chadha with the vision that nobody should suffer the way he has suffered because of lack and improper healthcare facilities in India. We need lots of funds manpower etc. to make this vision a reality please contact us. Join us as a member for a noble cause.

Brought to you by

Page 58: Treatment of  parkinson’s disease

Our views have increased the mark of the 20,000

Thank you viewers

Looking forward for franchise,

collaboration, partners. Brought to you by

Page 59: Treatment of  parkinson’s disease

011-25464531 ,011-41425180 ,011-66217387

+91-9818308353+,91-9818569476

[email protected]

. -www other mothe.r in

:// . . / / - - - /2242350https www facebook com pages Other Mother Nursing Crusade31114989? =ref hl

:// . . / / ? =326103341 = _http www linkedin com profile view id &trk nav responsi_ _ve tab profile

:// . /https twitter com othermotherindi

:// . . /https cparveen wix com other-mother

A WORLDWIDE MISSITION

Contact Us-:

JOIN US

Saxbee Consultants Details :-www.parveenchadha.com

Brought to you by